#USA #New York #Gross Law Firm #Caribou Biosciences #CRBU

Important Notice for Shareholders of Caribou Biosciences, Inc.

As a shareholder of Caribou Biosciences, Inc. (NASDAQ: CRBU), it is crucial for you to be aware of the legal opportunities available to you. The Gross Law Firm has announced an important notice for those who purchased shares in the timeframe from July 14, 2023, to July 16, 2024. If you fall under this category, you may have the option to join a class action lawsuit concerning significant allegations against the company.

Understanding the Allegations Against Caribou Biosciences

The complaint highlights several key issues regarding Caribou's business practices and disclosures during the aforementioned class period. Specifically, the allegations center on the claim that the defendants failed to disclose critical information that misled investors about the company's product, CB-010. Reportedly, the claims include an overstated depiction of CB-010’s safety, efficacy, and durability compared to existing approved CAR-T therapies. Furthermore, there is concern regarding the sufficiency of the company's cash and liquidity to support ongoing business operations, particularly in preclinical research related to their allogeneic CAR-NK platform.

The repercussions of these alleged inaccuracies could lead to severe negative impacts on Caribou's financial health and operational stability. Thus, shareholders are urged to evaluate their options swiftly as the deadline for registering for this class action is fast approaching. The firm strongly advises not to delay if you wish to participate in any potential recovery.

Next Steps for Participating Shareholders

If you have purchased shares of CRBU and are interested in being part of this class action, it is crucial to register your details with The Gross Law Firm. By doing so, you will also gain access to portfolio monitoring tools, which can keep you updated with the progress of your involvement in this case. Remember, the final date to seek appointment as a lead plaintiff is February 24, 2025, and participation in the class action comes at no cost to you.

The Gross Law Firm, recognized nationally for its efforts in protecting investor rights, is devoted to ensuring that companies adhere to ethical and transparent business practices. Their firm is committed to helping those who have incurred losses due to misleading corporate conduct.

For further information and assistance, you can reach out directly to The Gross Law Firm at:

• - Email: [email protected]
• - Phone: (646) 453-8903
• - Address: The Gross Law Firm, 15 West 38th Street, 12th floor, New York, NY, 10018

Conclusion

In conclusion, if you are an investor in Caribou Biosciences, Inc., it is in your best interest to reach out to The Gross Law Firm before the approaching deadline. Understanding your rights and options could make a significant difference in your investment journey, especially in light of the potential implications of these allegations. Don’t hesitate to take action and secure your position among other affected shareholders.